{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T07:07:05Z","timestamp":1777792025798,"version":"3.51.4"},"reference-count":218,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["LO 612\/16\\u20131"],"award-info":[{"award-number":["LO 612\/16\\u20131"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.pharmthera.2022.108312","type":"journal-article","created":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T20:13:22Z","timestamp":1669061602000},"page":"108312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Pharmacological data science perspective on fatal incidents of morphine treatment"],"prefix":"10.1016","volume":"241","author":[{"given":"Yazan","family":"Noufal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario","family":"Kringel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan W.","family":"Toennes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Dudziak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rn","family":"L\u00f6tsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2022.108312_bb0005","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/00000542-200005000-00038","article-title":"Insidious intoxication after morphine treatment in renal failure: Delayed onset of morphine-6-glucuronide action","volume":"92","author":"Angst","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0010","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/00000542-200005000-00038","article-title":"Insidious intoxication after morphine treatment in renal failure: Delayed onset of Morphine-6-glucuronide action","volume":"92","author":"Angst","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0015","first-page":"PL47","article-title":"Increased brain P-glycoprotein in morphine tolerant rats","volume":"66","author":"Aquilante","year":"2000","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0020","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0885-3924(97)00020-1","article-title":"Plasma morphine and glucuronide (M3G and M6G) concentrations in hospice inpatients","volume":"14","author":"Ashby","year":"1997","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0025","series-title":"Abstract 11th world congress of pain, international association for the study of pain, program no. 1073-P515","article-title":"Genetic variation in the gene for P-glycoprotein: Implications for the clinical efficacy of morphine","author":"Baar","year":"2005"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0030","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0024-3205(94)00552-4","article-title":"The excitatory effects of morphine-3-glucuronide are attenuated by LY274614, a competitive NMDA receptor antagonist, and by midazolam, an agonist at the benzodiazepine site on the GABAA receptor complex","volume":"54","author":"Bartlett","year":"1994","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/toxics9120356","article-title":"Forensic toxicological and medico-legal evaluation in a case of incongruous drug administration in terminal cancer patients","volume":"9","author":"Basilicata","year":"2021","journal-title":"Toxics"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0040","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1074\/jbc.M006352200","article-title":"A single nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs receptor signaling","volume":"276","author":"Befort","year":"2001","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0045","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/(SICI)1097-0142(19990901)86:5<871::AID-CNCR25>3.0.CO;2-L","article-title":"High dose morphine use in the hospice setting. A database survey of patient characteristics and effect on life expectancy","volume":"86","author":"Bercovitch","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0050","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0022-3565(25)20113-6","article-title":"Poor permeability of morphine 3-glucuronide and morphine 6-glucuronide through the blood-brain barrier in the rat","volume":"278","author":"Bickel","year":"1996","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0055","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/03602537508993748","article-title":"The metabolism of morphine and heroin in man","volume":"4","author":"Boerner","year":"1975","journal-title":"Drug Metabolism Reviews"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0060","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/MLR.0000000000000505","article-title":"A detailed exploration into the association of prescribed opioid dosage and overdose deaths among patients with chronic pain","volume":"54","author":"Bohnert","year":"2016","journal-title":"Medical Care"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0065","doi-asserted-by":"crossref","first-page":"9608","DOI":"10.1073\/pnas.95.16.9608","article-title":"Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: Possible implications for opiate addiction","volume":"95","author":"Bond","year":"1998","journal-title":"Proc.Natl.Acad.Sci.U.S.A"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0070","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1046\/j.1471-4159.2003.01990.x","article-title":"Evidence for an active transport of morphine-6-beta-d-glucuronide but not P-glycoprotein-mediated at the blood-brain barrier","volume":"86","author":"Bourasset","year":"2003","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0075","first-page":"11","article-title":"Postmortem metabolomics: Strategies to assess time-dependent postmortem changes of diazepam, nordiazepam, morphine, codeine, mirtazapine and citalopram","author":"Brockbals","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0080","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0022-3565(24)36961-7","article-title":"3H-morphine-6beta-glucuronide binding in brain membranes and an MOR-1- transfected cell line","volume":"282","author":"Brown","year":"1997","journal-title":"J.Pharmacol.Exp.Ther."},{"key":"10.1016\/j.pharmthera.2022.108312_bb0085","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1520\/JFS15225J","article-title":"Unexpected death due to infectious mononucleosis","volume":"47","author":"Byard","year":"2002","journal-title":"Journal of Forensic Sciences"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0090","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jcfm.2004.10.007","article-title":"Narcotic administration and stenosing lesions of the upper airway--a potentially lethal combination","volume":"12","author":"Byard","year":"2005","journal-title":"Journal of Clinical Forensic Medicine"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0095","article-title":"Variability in alfentanil analgesia maybe attributed to polymorphism in the mu-opiod receptor gene","volume":"69","author":"Caraco","year":"2001","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0100","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00000542-198703000-00011","article-title":"Morphine pharmacokinetics in renal failure","volume":"66","author":"Chauvin","year":"1987","journal-title":"Anesthesiology"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0105","first-page":"1","article-title":"Drug-poisoning deaths involving opioid analgesics: United States, 1999-2011","author":"Chen","year":"2014","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0110","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.bja.2021.06.049","article-title":"Association between opioid-related deaths and prescribed opioid dose and psychotropic medicines in England: A case-crossover study","volume":"127","author":"Chen","year":"2021","journal-title":"British Journal of Anaesthesia"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0115","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/pds.4619","article-title":"Comparative out-of-hospital mortality of long-acting opioids prescribed for non-cancer pain: A retrospective cohort study","volume":"28","author":"Chung","year":"2019","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0120","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/ajh.21051","article-title":"UGT2B7 promoter variant -840G>A contributes to the variability in hepatic clearance of morphine in patients with sickle cell disease","volume":"83","author":"Darbari","year":"2008","journal-title":"American Journal of Hematology"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0125","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0304-3959(92)90091-O","article-title":"Diclofenac does not modify morphine bioavailability in cancer patients","volume":"48","author":"De Conno","year":"1992","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0130","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1007\/s00228-013-1523-7","article-title":"Genetic variability at COMT but not at OPRM1 and UGT2B7 loci modulates morphine analgesic response in acute postoperative pain","volume":"69","author":"De Gregori","year":"2013","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0135","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/hmg\/ddi013","article-title":"Genetic basis for individual variations in pain perception and the development of a chronic pain condition","volume":"14","author":"Diatchenko","year":"2005","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0140","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1365-2125.2000.00226.x","article-title":"Effect of P-glycoprotein modulation on the clinical pharmacokinetics and adverse effects of morphine","volume":"50","author":"Drewe","year":"2000","journal-title":"Br.J.Clin.Pharmacol."},{"key":"10.1016\/j.pharmthera.2022.108312_bb0145","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/archinte.1916.00080130010002","article-title":"A formula to estimate the approximate surface area if height and weight be known","volume":"17","author":"Dubois","year":"1916","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0150","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/1742-2094-9-200","article-title":"Neuroexcitatory effects of morphine-3-glucuronide are dependent on Toll-like receptor 4 signaling","volume":"9","author":"Due","year":"2012","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0155","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s11926-006-0034-2","article-title":"Genetic predictors of acute and chronic pain","volume":"8","author":"Edwards","year":"2006","journal-title":"Current Rheumatology Reports"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0160","series-title":"An introduction to the bootstrap","author":"Efron","year":"1995"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0165","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0885-3924(95)00148-4","article-title":"Morphine and morphine-6-glucuronide plasma concentrations and effect in cancer pain","volume":"11","author":"Faura","year":"1996","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0170","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0300-9432(74)90010-7","article-title":"Morphine concentrations in blood and organs in cases of fatal poisoning","volume":"3","author":"Felby","year":"1974","journal-title":"Forensic Science"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0175","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1365-2125.2008.03231.x","article-title":"Post-mortem clinical pharmacology","volume":"66","author":"Ferner","year":"2008","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0180","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0304-3959(03)00318-X","article-title":"Initial pharmacokinetic, safety and efficacy evaluation of nasal morphine gluconate for breakthrough pain in cancer patients","volume":"106","author":"Fitzgibbon","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0185","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/jcp.46.4.292","article-title":"ACP broadsheet no 137: April 1993. Obtaining samples at post mortem examination for toxicological and biochemical analyses","volume":"46","author":"Forrest","year":"1993","journal-title":"Journal of Clinical Pathology"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0190","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ajim.20191","article-title":"Opioid dosing trends and mortality in Washington State workers\u2019 compensation, 1996-2002","volume":"48","author":"Franklin","year":"2005","journal-title":"American Journal of Industrial Medicine"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0195","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.forsciint.2016.02.051","article-title":"Post-mortem levels and tissue distribution of codeine, codeine-6-glucuronide, norcodeine, morphine and morphine glucuronides in a series of codeine-related deaths","volume":"262","author":"Frost","year":"2016","journal-title":"Forensic Science International"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0200","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00280-009-1029-2","article-title":"Association of UGT2B7 and ABCB1 genotypes with morphine-induced adverse drug reactions in Japanese patients with cancer","volume":"65","author":"Fujita","year":"2010","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0205","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1360-0443.2004.00744.x","article-title":"Comparison of acute lethal toxicity of commonly abused psychoactive substances","volume":"99","author":"Gable","year":"2004","journal-title":"Addiction"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0210","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pharmthera.2010.01.002","article-title":"Chemokines, neuronal-glial interactions, and central processing of neuropathic pain","volume":"126","author":"Gao","year":"2010","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0215","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/MLR.0000000000000738","article-title":"Patterns of opioid use and risk of opioid overdose death among medicaid patients","volume":"55","author":"Garg","year":"2017","journal-title":"Medical Care"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0220","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/PAF.0000000000000623","article-title":"Differences between central and peripheral postmortem tryptase levels","volume":"42","author":"Garland","year":"2021","journal-title":"The American Journal of Forensic Medicine and Pathology"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0225","doi-asserted-by":"crossref","first-page":"7499","DOI":"10.1073\/pnas.0400280101","article-title":"From the cover: Diffusion-based method for producing density-equalizing maps","volume":"101","author":"Gastner","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0230","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s12024-012-9341-2","article-title":"The effect of the postmortem interval on the redistribution of drugs: A comparison of mortuary admission and autopsy blood specimens","volume":"8","author":"Gerostamoulos","year":"2012","journal-title":"Forensic Science, Medicine, and Pathology"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0235","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1520\/JFS14781J","article-title":"Postmortem redistribution of morphine and its metabolites","volume":"45","author":"Gerostamoulos","year":"2000","journal-title":"Journal of Forensic Sciences"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0240","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/jat\/19.6.392","article-title":"A 5-year stability study of common illicit drugs in blood","volume":"19","author":"Giorgi","year":"1995","journal-title":"Journal of Analytical Toxicology"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0245","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/jat\/23.2.130","article-title":"Self-intoxication with morphine obtained from an infusion pump","volume":"23","author":"Gock","year":"1999","journal-title":"Journal of Analytical Toxicology"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0250","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0304-3959(92)90065-J","article-title":"Morphine-3-glucuronide may functionally antagonize morphine-6- glucuronide induced antinociception and ventilatory depression in the rat","volume":"48","author":"Gong","year":"1992","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108291","article-title":"All-cause mortality among males living with and without HIV initiating long-term opioid therapy, and its association with opioid dose, opioid interruption and other factors","volume":"216","author":"Gordon","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0260","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0304-3959(85)90001-6","article-title":"Cephalad migration of morphine in CSF following lumbar epidural administration in patients with cancer pain","volume":"23","author":"Gourlay","year":"1985","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0265","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jpainsymman.2012.03.015","article-title":"Plasma morphine and metabolite concentrations are associated with clinical effects of morphine in cancer patients","volume":"45","author":"Gretton","year":"2013","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0270","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/00365519950185328","article-title":"Preanalytical factors and their influence on analytical quality specifications","volume":"59","author":"Guder","year":"1999","journal-title":"Scandinavian Journal of Clinical and Laboratory Investigation"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0275","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s004140050141","article-title":"Stability of morphine and buprenorphine in whole blood","volume":"111","author":"Hadidi","year":"1998","journal-title":"International Journal of Legal Medicine"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0280","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0024-3205(99)00239-8","article-title":"Brain region-specific studies of the excitatory behavioral effects of morphine-3-glucuronide","volume":"65","author":"Halliday","year":"1999","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0285","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/jat\/12.4.234","article-title":"Comparison of whole blood and plasma morphine","volume":"12","author":"Hand","year":"1988","journal-title":"Journal of Analytical Toxicology"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0290","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1126\/science.28.706.49","article-title":"Mendelian proportions in a mixed population","volume":"28","author":"Hardy","year":"1908","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0295","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/PAF.0000000000000044","article-title":"Peripheral postmortem redistribution of morphine","volume":"35","author":"Hargrove","year":"2014","journal-title":"The American Journal of Forensic Medicine and Pathology"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0300","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1345\/aph.1K066","article-title":"Rates of adverse events of long-acting opioids in a state Medicaid program","volume":"41","author":"Hartung","year":"2007","journal-title":"The Annals of Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0305","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jclinane.2005.03.004","article-title":"Effects of morphine and its metabolites on immune function in advanced cancer patients","volume":"17","author":"Hashiguchi","year":"2005","journal-title":"Journal of Clinical Anesthesia"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0310","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2125.1990.tb03638.x","article-title":"The metabolism and bioavailability of morphine in patients with severe liver cirrhosis","volume":"29","author":"Hasselstr\u00f6m","year":"1990","journal-title":"Br.J.Clin.Pharmacol."},{"key":"10.1016\/j.pharmthera.2022.108312_bb0315","first-page":"1","article-title":"Regional differences in the drugs most frequently involved in drug overdose deaths: United States, 2017","volume":"68","author":"Hedegaard","year":"2019","journal-title":"National Vital Statistics Reports"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0320","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/bmj.319.7210.627","article-title":"Morphine induced allodynia in a child with brain tumour","volume":"319","author":"Heger","year":"1999","journal-title":"Bmj"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0325","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1080\/02841860050215927","article-title":"Morphine or oxycodone in cancer pain?","volume":"39","author":"Heiskanen","year":"2000","journal-title":"Acta Oncologica"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0330","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1520\/JFS12023J","article-title":"The extent of postmortem drug redistribution in a rat model","volume":"44","author":"Hilberg","year":"1999","journal-title":"Journal of Forensic Sciences"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0335","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1136\/amiajnl-2013-002116","article-title":"ICD-10 codes used to identify adverse drug events in administrative data: A systematic review","volume":"21","author":"Hohl","year":"2014","journal-title":"Journal of the American Medical Informatics Association"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0340","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.forsciint.2014.03.008","article-title":"Long-term stability of morphine, codeine, and 6-acetylmorphine in real-life whole blood samples, stored at \u221220 degrees C","volume":"239","author":"Hoiseth","year":"2014","journal-title":"Forensic Science International"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0345","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00228-002-0490-1","article-title":"Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapy","volume":"58","author":"Holthe","year":"2002","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0350","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1365-2044.1989.tb09143.x","article-title":"Controlled-release morphine in cancer pain. Is a loading dose required when the formulation is changed?","volume":"44","author":"Hoskin","year":"1989","journal-title":"Anaesthesia"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0355","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1460-9568.2008.06321.x","article-title":"Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: Involvement of toll-like receptor 4 (TLR4)","volume":"28","author":"Hutchinson","year":"2008","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0360","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/10618600.1996.10474713","article-title":"R: A language for data analysis and graphics","volume":"5","author":"Ihaka","year":"1996","journal-title":"Journal of Computational and Graphical Statistics"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0365","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/j.pain.0000000000000484","article-title":"Opioid dose and risk of suicide","volume":"157","author":"Ilgen","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0370","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.2105\/AJPH.2018.304728","article-title":"Consistency between opioid-related mortality trends derived from poison center and national vital statistics system, United States, 2006-2016","volume":"108","author":"Iwanicki","year":"2018","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0375","first-page":"188","article-title":"Determination of blood\/serum ratios of different forensically relevant analytes in authentic samples","volume":"227","author":"Jantos","year":"2011","journal-title":"Archiv f\u00fcr Kriminologie"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0380","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/jat\/11.5.186","article-title":"Site dependence of drug concentrations in postmortem blood--a case study","volume":"11","author":"Jones","year":"1987","journal-title":"Journal of Analytical Toxicology"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0385","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.forsciint.2014.01.005","article-title":"Sedative and hypnotic drugs--fatal and non-fatal reference blood concentrations","volume":"236","author":"Jonsson","year":"2014","journal-title":"Forensic Science International"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0390","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1600-0773.1990.tb00838.x","article-title":"Morphine and oxycodone in the management of cancer pain: Plasma levels determined by chemical and radioreceptor assays","volume":"67","author":"Kalso","year":"1990","journal-title":"Pharmacology & Toxicology"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0395","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.clpt.2003.08.011","article-title":"Role of P-glycoprotein in the intestinal absorption and clinical effects of morphine","volume":"74","author":"Kharasch","year":"2003","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0400","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/85115","article-title":"Transport of opioids from the brain to the periphery by P-glycoprotein: Peripheral actions of central drugs","volume":"4","author":"King","year":"2001","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0405","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1191\/0269216303pm835oa","article-title":"Routine drug monitoring of serum concentrations of morphine, morphine-3-glucuronide and morphine-6-glucuronide do not predict clinical observations in cancer patients","volume":"17","author":"Klepstad","year":"2003","journal-title":"Palliative Medicine"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0410","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1034\/j.1399-6576.2003.00138.x","article-title":"Influences on serum concentrations of morphine, M6G and M3G during routine clinical drug monitoring: A prospective survey in 300 adult cancer patients","volume":"47","author":"Klepstad","year":"2003","journal-title":"Acta Anaesthesiologica Scandinavica"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0415","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/bja\/aei007","article-title":"Pharmacokinetics of controlled release morphine (MST) in patients with liver carcinoma","volume":"94","author":"Kotb","year":"2005","journal-title":"British Journal of Anaesthesia"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0420","series-title":"RISmed: Download content from NCBI databases","author":"Kovalchik","year":"2020"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0425","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.pain.2011.03.023","article-title":"Comparative mortality among Department of Veterans Affairs patients prescribed methadone or long-acting morphine for chronic pain","volume":"152","author":"Krebs","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.57.1.1","article-title":"Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments","volume":"57","author":"Kreek","year":"2005","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0435","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13148-019-0772-4","article-title":"Machine-learned analysis of global and glial\/opioid intersection-related DNA methylation in patients with persistent pain after breast cancer surgery","volume":"11","author":"Kringel","year":"2019","journal-title":"Clinical Epigenetics"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0440","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/ejp.690","article-title":"Pain research funding by the European Union Seventh Framework Programme","volume":"19","author":"Kringel","year":"2015","journal-title":"European Journal of Pain"},{"issue":"Dec 1","key":"10.1016\/j.pharmthera.2022.108312_bb0445","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cca.2016.10.009","article-title":"Next-generation sequencing of human opioid receptor genes based on a custom AmpliSeq library and ion torrent personal genome machine","volume":"463","author":"Kringel","year":"2016","journal-title":"Clinica Chimica Acta"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0450","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/tpj.2016.28","article-title":"Emergent biomarker derived from next-generation sequencing to identify pain patients requiring uncommonly high opioid doses","volume":"17","author":"Kringel","year":"2017","journal-title":"The Pharmacogenomics Journal"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0455","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.pharmthera.2017.10.006","article-title":"Toll-like receptors and their role in persistent pain","volume":"184","author":"Lacagnina","year":"2018","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0460","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/0006-2952(93)90462-6","article-title":"Effects of morphine and its metabolites on opiate receptor binding, cAMP formation and [3H]noradrenaline release from SH-SY5Y cells","volume":"46","author":"Lambert","year":"1993","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0465","series-title":"Rcartogram: Interface to Mark Newman\u2019s cartogram software","author":"Lang","year":"2020"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0470","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1080\/15563650.2019.1591430","article-title":"The relationship between antemortem and postmortem morphine concentrations","volume":"57","author":"Langford","year":"2019","journal-title":"Clinical Toxicology (Philadelphia, Pa.)"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0475","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1081\/CLT-120018270","article-title":"Post-mortem toxicology: What the dead can and cannot tell us","volume":"41","author":"Leikin","year":"2003","journal-title":"Journal of Toxicology. Clinical Toxicology"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0480","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1111\/1556-4029.13404","article-title":"Site-, technique-, and time-related aspects of the Postmortem redistribution of diazepam, methadone, morphine, and their metabolites: Interest of popliteal vein blood sampling","volume":"62","author":"Lemaire","year":"2017","journal-title":"Journal of Forensic Sciences"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0485","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0090-9556(24)11822-3","article-title":"Effects of a potent and specific P-glycoprotein inhibitor on the blood- brain barrier distribution and antinociceptive effect of morphine in the rat","volume":"27","author":"Letrent","year":"1999","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0490","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0379-0738(94)90294-1","article-title":"An unusual morphine fatality","volume":"65","author":"Levine","year":"1994","journal-title":"Forensic Science International"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0495","first-page":"45","article-title":"Astrocyte: A new star in pain research","volume":"34","author":"Li","year":"2003","journal-title":"Sheng Li Ke Xue Jin Zhan"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0500","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0379-0738(87)90055-7","article-title":"The measurement and interpretation of morphine in blood","volume":"35","author":"Logan","year":"1987","journal-title":"Forensic Science International"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0505","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/jat\/21.1.23","article-title":"Lack of predictable site-dependent differences and time-dependent changes in postmortem concentrations of cocaine, benzoylecgonine, and cocaethylene in humans","volume":"21","author":"Logan","year":"1997","journal-title":"Journal of Analytical Toxicology"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0510","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jpainsymman.2005.01.004","article-title":"Opioid metabolites","volume":"29","author":"L\u00f6tsch","year":"2005","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0515","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1016\/j.jpainsymman.2005.01.012","article-title":"Pharmacokinetic-pharmacodynamic modeling of opioids","volume":"29","author":"L\u00f6tsch","year":"2005","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0520","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/01.anes.0000268501.61048.18","article-title":"Basic genetic statistics are necessary in studies of functional associations in anesthesiology","volume":"107","author":"L\u00f6tsch","year":"2007","journal-title":"Anesthesiology"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0525","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2165\/00003088-200645110-00001","article-title":"Fatal respiratory depression after multiple intravenous morphine injections","volume":"45","author":"L\u00f6tsch","year":"2006","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0530","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2165\/00003088-200140070-00001","article-title":"Morphine-6-glucuronide: An analgesic of the future?","volume":"40","author":"L\u00f6tsch","year":"2001","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0535","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.molmed.2004.12.006","article-title":"Are mu-opioid receptor polymorphisms important for clinical opioid therapy?","volume":"11","author":"L\u00f6tsch","year":"2005","journal-title":"Trends in Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0540","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1476-5381.2010.01074.x","article-title":"Pharmacogenetics of new analgesics","volume":"163","author":"L\u00f6tsch","year":"2011","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0545","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.pharmthera.2009.06.010","article-title":"Genetic modulation of the pharmacological treatment of pain","volume":"124","author":"L\u00f6tsch","year":"2009","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0550","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1471-4159.2002.01177.x","article-title":"Increased CNS uptake and enhanced antinociception of morphine-6-glucuronide in rats after inhibition of P-glycoprotein","volume":"83","author":"L\u00f6tsch","year":"2002","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0555","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2165\/00003088-200443140-00003","article-title":"Genetic predictors of the clinical response to opioid analgesics: Clinical utility and future perspectives","volume":"43","author":"L\u00f6tsch","year":"2004","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0560","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/00000542-200112000-00009","article-title":"The transfer half-life of morphine-6-glucuronide from plasma to effect site assessed by pupil size measurement in healthy volunteers","volume":"95","author":"Lotsch","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0565","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/00000542-200112000-00009","article-title":"The transfer half-life of morphine-6-beta-glucuronide from plasma to effect site assessed by pupil size measurement in healthy volunteers","volume":"95","author":"L\u00f6tsch","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0570","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1067\/mcp.2002.126172","article-title":"Pharmacokinetic modeling to predict morphine and morphine-6-glucuronide plasma concentrations in healthy young volunteers","volume":"72","author":"L\u00f6tsch","year":"2002","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0575","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0009-9236(96)90058-2","article-title":"Pharmacokinetics of morphine and its glucuronides after i.v.-infusion of morphine and morphine-6-glucuronide in healthy volunteers","volume":"60","author":"L\u00f6tsch","year":"1996","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0580","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1016\/S0024-3205(00)00569-5","article-title":"Antinociceptive effects of morphine-6-glucuronide in homozygous MDR1a P-glycoprotein knockout and in wildtype mice in the hotplate test","volume":"66","author":"L\u00f6tsch","year":"2000","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0585","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/00000542-199904000-00016","article-title":"Pharmacokinetic modeling of M6G formation after oral administration of morphine in healthy volunteers","volume":"90","author":"L\u00f6tsch","year":"1999","journal-title":"Anesthesiology"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0590","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/00000542-200210000-00011","article-title":"Does the A118G polymorphism at the mu-opioid receptor gene protect against morphine-6-glucuronide toxicity?","volume":"97","author":"L\u00f6tsch","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0595","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3758\/s13428-019-01246-w","article-title":"Robust statistical methods in R using the WRS2 package","volume":"52","author":"Mair","year":"2020","journal-title":"Behavior Research Methods"},{"issue":"4","key":"10.1016\/j.pharmthera.2022.108312_bb0600","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/jat\/bkaa107","article-title":"Postmortem drug redistribution: A compilation of postmortem\/antemortem drug concentration ratios","volume":"45","author":"Mantinieks","year":"2020","journal-title":"Journal of Analytical Toxicology"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.fpc.0000182781.87932.0d","article-title":"Pharmacogenetics of opioid receptors and addiction","volume":"16","author":"Mayer","year":"2006","journal-title":"Pharmacogenetics and Genomics"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0610","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/clpt.1990.145","article-title":"Oral morphine in cancer pain: Influences on morphine and metabolite concentration","volume":"48","author":"McQuay","year":"1990","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0615","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.pop.2019.05.008","article-title":"Palliative care approach to chronic diseases: End stages of heart failure, chronic obstructive pulmonary disease, liver failure, and renal failure","volume":"46","author":"Mechler","year":"2019","journal-title":"Primary Care"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0620","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0379-0738(02)00343-2","article-title":"Fatal versus non-fatal heroin \u201coverdose\u201d: Blood morphine concentrations with fatal outcome in comparison to those of intoxicated drivers","volume":"130","author":"Meissner","year":"2002","journal-title":"Forensic Science International"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0625","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1111\/1556-4029.12541","article-title":"Underrepresentation of heroin involvement in unintentional drug overdose deaths in Allegheny County, PA","volume":"59","author":"Mertz","year":"2014","journal-title":"Journal of Forensic Sciences"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0630","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/j.1556-4029.2010.01408.x","article-title":"Concentrations of opiates and psychotropic agents in polydrug overdoses: A surprising correlation between morphine and antidepressants","volume":"55","author":"Minett","year":"2010","journal-title":"Journal of Forensic Sciences"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0635","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00228-012-1228-3","article-title":"Serum concentrations of opioids when comparing two switching strategies to methadone for cancer pain","volume":"68","author":"Moksnes","year":"2012","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0640","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1520\/JFS14195J","article-title":"Distribution of free and conjugated morphine in body fluids and tissues in a fatal heroin overdose: Is conjugated morphine stable in postmortem specimens?","volume":"42","author":"Moriya","year":"1997","journal-title":"Journal of Forensic Sciences"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0645","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s40264-018-0660-4","article-title":"Comparative rates of mortality and serious adverse effects among commonly prescribed opioid analgesics","volume":"41","author":"Murphy","year":"2018","journal-title":"Drug Safety"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0650","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.forsciint.2019.06.007","article-title":"Brain-blood ratio of morphine in heroin and morphine autopsy cases","volume":"301","author":"Nedahl","year":"2019","journal-title":"Forensic Science International"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0655","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0304-3959(82)90014-8","article-title":"Plasma morphine concentrations during chronic oral administration in patients with cancer pain","volume":"13","author":"Neumann","year":"1982","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0660","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.2215\/CJN.00440119","article-title":"Associations of opioid prescriptions with death and hospitalization across the spectrum of estimated GFR","volume":"14","author":"Novick","year":"2019","journal-title":"Clinical Journal of the American Society of Nephrology"},{"issue":"5","key":"10.1016\/j.pharmthera.2022.108312_bb0665","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1111\/add.15768","article-title":"Using death scene and toxicology evidence to define involvement of heroin, pharmaceutical morphine, illicitly manufactured fentanyl and pharmaceutical fentanyl in opioid overdose deaths, 38 states and the District of Columbia, January 2018-December 2019","volume":"117","author":"O\u2019Donnell","year":"2021","journal-title":"Addiction."},{"key":"10.1016\/j.pharmthera.2022.108312_bb0670","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2217\/14622416.9.2.179","article-title":"Genetic mutations that prevent pain: Implications for future pain medication","volume":"9","author":"Oertel","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0675","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1093\/hmg\/dds314","article-title":"Genetic-epigenetic interaction modulates mu-opioid receptor regulation","volume":"21","author":"Oertel","year":"2012","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0680","doi-asserted-by":"crossref","first-page":"6530","DOI":"10.1074\/jbc.M807030200","article-title":"A common human micro-opioid receptor genetic variant diminishes the receptor signaling efficacy in brain regions processing the sensory information of pain","volume":"284","author":"Oertel","year":"2009","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0685","doi-asserted-by":"crossref","first-page":"474","DOI":"10.6061\/clinics\/2016(08)11","article-title":"Metabolism and pharmacokinetics of morphine in neonates: A review","volume":"71","author":"Pacifici","year":"2016","journal-title":"Clinics (S\u00e3o Paulo, Brazil)"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0690","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/1556-4029.12337","article-title":"Stability of morphine, codeine, and 6-acetylmorphine in blood at different sampling and storage conditions","volume":"59","author":"Papoutsis","year":"2014","journal-title":"Journal of Forensic Sciences"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0695","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/nature07830","article-title":"The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex","volume":"458","author":"Park","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0700","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0379-0738(85)90175-6","article-title":"Drug levels found in cases of fatal self-poisoning","volume":"27","author":"Paterson","year":"1985","journal-title":"Forensic Science International"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0705","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/jat\/27.8.533","article-title":"Mechanisms underlying postmortem redistribution of drugs: A review","volume":"27","author":"Pelissier-Alicot","year":"2003","journal-title":"Journal of Analytical Toxicology"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0710","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1067\/mcp.2000.111934","article-title":"Randomized placebo controlled trial of the activity of the morphine glucuronides","volume":"68","author":"Penson","year":"2000","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0715","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/jps.1131","article-title":"Limited phase I study of morphine-3-glucuronide","volume":"90","author":"Penson","year":"2001","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0720","doi-asserted-by":"crossref","first-page":"83","DOI":"10.5055\/jom.2005.0021","article-title":"Morphine analgesia in cancer pain: Role of the glucuronides","volume":"1","author":"Penson","year":"2005","journal-title":"Journal of Opioid Management"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0725","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF00265969","article-title":"Plasma levels of morphine and morphine glucuronides in the treatment of cancer pain: Relationship to renal function and route of administration","volume":"38","author":"Peterson","year":"1990","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0730","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/MLR.0000000000000944","article-title":"Overview of prescription opioid deaths in the Oklahoma State medicaid population, 2012-2016","volume":"56","author":"Pham","year":"2018","journal-title":"Medical Care"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0735","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0379-0738(95)01797-6","article-title":"Fatal morphine poisoning in a child due to accidental oral ingestion","volume":"76","author":"Poklis","year":"1995","journal-title":"Forensic Science International"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0740","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1212\/WNL.41.9.1457","article-title":"Chronic morphine therapy for cancer pain: Plasma and cerebrospinal fluid morphine and morphine-6-glucuronide concentrations","volume":"41","author":"Portenoy","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0745","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0379-0738(90)90182-X","article-title":"Post-mortem drug redistribution--a toxicological nightmare","volume":"45","author":"Pounder","year":"1990","journal-title":"Forensic Science International"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0750","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1520\/JFS12828J","article-title":"The forensic science implications of site and temporal influences on postmortem blood-drug concentrations","volume":"35","author":"Prouty","year":"1990","journal-title":"Journal of Forensic Sciences"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0755","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1191\/0269216303pm658oa","article-title":"Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain","volume":"17","author":"Quigley","year":"2003","journal-title":"Palliative Medicine"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0760","series-title":"R: A language and environment for statistical computing","author":"R Development Core Team","year":"2008"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0765","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pain.2005.03.032","article-title":"The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients","volume":"116","author":"Rakvag","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0770","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/00000542-200310000-00008","article-title":"Pharmacodynamic effect of morphine-6-glucuronide versus morphine on hypoxic and hypercapnic breathing in healthy volunteers","volume":"99","author":"Romberg","year":"2003","journal-title":"Anesthesiology"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0775","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1007\/s11606-018-4532-5","article-title":"Potentially inappropriate opioid prescribing, overdose, and mortality in Massachusetts, 2011-2015","volume":"33","author":"Rose","year":"2018","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0780","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.drugalcdep.2017.07.018","article-title":"Trends in heroin and pharmaceutical opioid overdose deaths in Australia","volume":"179","author":"Roxburgh","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0785","series-title":"Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics","first-page":"119","volume":"15","author":"Sadhasivam","year":"2015"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0790","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s11096-010-9430-9","article-title":"Relationship between plasma concentrations of morphine and its metabolites and pain in cancer patients","volume":"32","author":"Sakurada","year":"2010","journal-title":"Pharmacy World & Science"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0795","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11606-021-06792-8","article-title":"Do formulation and dose of long-term opioid therapy contribute to risk of adverse events among older adults?","volume":"37","author":"Salkar","year":"2022","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0800","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0304-3959(87)90018-2","article-title":"CSF and plasma morphine concentrations in cancer patients during chronic epidural morphine therapy and its relation to pain relief","volume":"30","author":"Samuelsson","year":"1987","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0805","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/BF00543973","article-title":"Kinetics of morphine in patients with renal failure","volume":"32","author":"Sawe","year":"1987","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0810","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0379-0738(88)90172-7","article-title":"Postmortem disposition of morphine in rats","volume":"38","author":"Sawyer","year":"1988","journal-title":"Forensic Science International"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0815","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00414-017-1754-8","article-title":"The feasibility of physiologically based pharmacokinetic modeling in forensic medicine illustrated by the example of morphine","volume":"132","author":"Schaefer","year":"2018","journal-title":"International Journal of Legal Medicine"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0820","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.15585\/mmwr.mm675152e1","article-title":"Drug and opioid-involved overdose deaths - United States, 2013-2017","volume":"67","author":"Scholl","year":"2018","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0825","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/nn1992","article-title":"The neuropathic pain triad: Neurons, immune cells and glia","volume":"10","author":"Scholz","year":"2007","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0830","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2019.109970","article-title":"Post-mortem analysis of prescription opioids-A follow-up examination by LC-MS\/MS with focus on fentanyl","volume":"305","author":"Schonfeld","year":"2019","journal-title":"Forensic Science International"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0835","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13054-020-02915-5","article-title":"Revisited: Therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics","volume":"24","author":"Schulz","year":"2020","journal-title":"Critical Care"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0840","first-page":"135","article-title":"Opioid rotation in cancer pain treatment","volume":"115","author":"Schuster","year":"2018","journal-title":"Deutsches \u00c4rzteblatt International"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0845","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10519-015-9737-3","article-title":"Association of the OPRM1 variant rs1799971 (A118G) with non-specific liability to substance dependence in a collaborative de novo meta-analysis of European-ancestry cohorts","volume":"46","author":"Schwantes-An","year":"2016","journal-title":"Behavior Genetics"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0850","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/bja\/62.1.28","article-title":"Studies on morphine disposition: Influence of renal failure on the kinetics of morphine and its metabolites","volume":"62","author":"Sear","year":"1989","journal-title":"British Journal of Anaesthesia"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0855","first-page":"47","article-title":"Darstellung der reinen Mohns\u00e4ure (Opiums\u00e4ure) nebst einer chemischen Untersuchung des Opiums","volume":"14","author":"Sert\u00fcrner","year":"1806","journal-title":"J Pharmacie"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0860","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.tips.2019.04.003","article-title":"Novel approaches to persistent pain therapy","volume":"40","author":"Sisignano","year":"2019","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0865","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1067\/mcp.2003.5","article-title":"Analgesic effects of morphine and morphine-6-glucuronide in a transcutaneous electrical pain model in healthy volunteers","volume":"73","author":"Skarke","year":"2003","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0870","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pain.2005.06.006","article-title":"Is morphine-3-glucuronide of therapeutic relevance?","volume":"116","author":"Skarke","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0875","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0009-9236(03)00220-0","article-title":"Respiratory and miotic effects of morphine in healthy volunteers when P-glycoprotein is blocked by quinidine","volume":"74","author":"Skarke","year":"2003","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0880","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.forsciint.2004.02.012","article-title":"Preanalytic aspects in postmortem toxicology","volume":"142","author":"Skopp","year":"2004","journal-title":"Forensic Science International"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0885","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/BF01369670","article-title":"Postmortem distribution pattern of morphine and morphine glucuronides in heroin overdose","volume":"109","author":"Skopp","year":"1996","journal-title":"International Journal of Legal Medicine"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0890","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jat\/22.4.261","article-title":"A preliminary study on the distribution of morphine and its glucuronides in the subcompartments of blood","volume":"22","author":"Skopp","year":"1998","journal-title":"Journal of Analytical Toxicology"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0895","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/jat\/25.1.2","article-title":"Stability of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in fresh blood and plasma and postmortem blood samples","volume":"25","author":"Skopp","year":"2001","journal-title":"Journal of Analytical Toxicology"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0900","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0024-3205(90)90619-3","article-title":"Morphine-3-glucuronide--a potent antagonist of morphine analgesia","volume":"47","author":"Smith","year":"1990","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0905","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1213\/00000539-199901000-00021","article-title":"Cerebrospinal fluid and plasma concentrations of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in patients before and after initiation of intracerebroventricular morphine for cancer pain management","volume":"88","author":"Smith","year":"1999","journal-title":"Anesthesia and Analgesia"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0910","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/sj.clpt.6100095","article-title":"Pharmacogenetics of opioids","volume":"81","author":"Somogyi","year":"2007","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0915","first-page":"1","article-title":"National hospital care survey demonstration projects: Opioid-involved emergency department visits, hospitalizations, and deaths","author":"Spencer","year":"2020","journal-title":"Natl Health Stat Report"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0920","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00414-016-1485-2","article-title":"Time-dependent postmortem redistribution of morphine and its metabolites in blood and alternative matrices-application of CT-guided biopsy sampling","volume":"131","author":"Staeheli","year":"2017","journal-title":"International Journal of Legal Medicine"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0925","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1517\/14656566.8.14.2235","article-title":"The pharmacogenetics of analgesia","volume":"8","author":"Stamer","year":"2007","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0930","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jcfm.2004.04.008","article-title":"Blood free morphine levels vary with concomitant alcohol and benzodiazepine use","volume":"11","author":"Stenhouse","year":"2004","journal-title":"Journal of Clinical Forensic Medicine"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0935","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejps.2015.03.020","article-title":"A review of morphine and morphine-6-glucuronide\u2019s pharmacokinetic-pharmacodynamic relationships in experimental and clinical pain","volume":"74","author":"Sverrisdottir","year":"2015","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0940","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejps.2015.03.020","article-title":"A review of morphine and morphine-6-glucuronide\u2019s pharmacokinetic-pharmacodynamic relationships in experimental and clinical pain","volume":"74","author":"Sverrisd\u00f3ttir","year":"2015","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0945","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1191\/0269216303pm824oa","article-title":"The oral-to-intravenous equianalgesic ratio of morphine based on plasma concentrations of morphine and metabolites in advanced cancer patients receiving chronic morphine treatment","volume":"17","author":"Takahashi","year":"2003","journal-title":"Palliative Medicine"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0950","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2165\/00003088-199937010-00002","article-title":"Pharmacokinetics of opioids in liver disease","volume":"37","author":"Tegeder","year":"1999","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0955","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1093\/brain\/awg115","article-title":"Peripheral opioid analgesia in experimental human pain models","volume":"126","author":"Tegeder","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0960","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/jat\/bky002","article-title":"Metabolites of heroin in several different post-mortem matrices","volume":"42","author":"Thaulow","year":"2018","journal-title":"Journal of Analytical Toxicology"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0965","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1742-2094-9-155","article-title":"Neuroimmune crosstalk in the central nervous system and its significance for neurological diseases","volume":"9","author":"Tian","year":"2012","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0970","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/jat\/34.8.491","article-title":"Evaluating the relationship between postmortem and antemortem morphine and codeine concentrations in whole blood","volume":"34","author":"Tolliver","year":"2010","journal-title":"Journal of Analytical Toxicology"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0975","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.injury.2021.03.018","article-title":"Opioids and injury deaths: A population-based analysis of the United States from 2006 to 2017","volume":"52","author":"Truong","year":"2021","journal-title":"Injury"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0980","series-title":"Exploratory data analysis","author":"Tukey","year":"1977"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0985","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(95)92281-4","article-title":"Driving ability in cancer patients receiving long-term morphine analgesia","volume":"346","author":"Vainio","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0990","series-title":"Modern applied statistics with S","author":"Venables","year":"2002"},{"key":"10.1016\/j.pharmthera.2022.108312_bb0995","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s002280050387","article-title":"Variability of morphine disposition during long-term subcutaneous infusion in terminally ill cancer patients","volume":"53","author":"Vermeire","year":"1998","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2022.108312_bb1000","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s11524-015-9967-y","article-title":"Opioid overdose deaths in the City and County of San Francisco: Prevalence, distribution, and disparities","volume":"92","author":"Visconti","year":"2015","journal-title":"Journal of Urban Health"},{"key":"10.1016\/j.pharmthera.2022.108312_bb1005","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.clinbiochem.2008.02.017","article-title":"A decade of HPLC-MS\/MS in the routine clinical laboratory--goals for further developments","volume":"41","author":"Vogeser","year":"2008","journal-title":"Clinical Biochemistry"},{"key":"10.1016\/j.pharmthera.2022.108312_bb1010","first-page":"780","article-title":"Oral morphine and respiratory function amongst hospice inpatients with advanced cancer","volume":"11","author":"Walsh","year":"2003","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.pharmthera.2022.108312_bb1015","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.2217\/pgs.13.187","article-title":"\u03bc-opioid receptor gene variant OPRM1 118 A>G: A summary of its molecular and clinical consequences for pain","volume":"14","author":"Walter","year":"2013","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.pharmthera.2022.108312_bb1020","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/00000542-200204000-00019","article-title":"Interaction of morphine, fentanyl, sufentanil, alfentanil, and loperamide with the efflux drug transporter P-glycoprotein","volume":"96","author":"Wandel","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1016\/j.pharmthera.2022.108312_bb1025","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1600-0773.1996.tb00184.x","article-title":"The influence of preanalytical factors on concentrations of morphine and metabolites in patients receiving morphine","volume":"78","author":"Westerling","year":"1996","journal-title":"Pharmacology & Toxicology"},{"key":"10.1016\/j.pharmthera.2022.108312_bb1030","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00007691-199506000-00013","article-title":"Plasma concentrations of morphine, morphine-3-glucuronide, and morphine- 6-glucuronide after intravenous and oral administration to healthy volunteers: Relationship to nonanalgesic actions","volume":"17","author":"Westerling","year":"1995","journal-title":"Therapeutic Drug Monitoring"},{"key":"10.1016\/j.pharmthera.2022.108312_bb1035","series-title":"WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents","volume":"Vol. 2022","author":"WHO","year":"2018"},{"key":"10.1016\/j.pharmthera.2022.108312_bb1040","series-title":"ggplot2: Elegant graphics for data analysis","author":"Wickham","year":"2009"},{"key":"10.1016\/j.pharmthera.2022.108312_bb1045","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/BF02294395","article-title":"The percentage bend correlation coefficient","volume":"59","author":"Wilcox","year":"1994","journal-title":"Psychometrika"},{"key":"10.1016\/j.pharmthera.2022.108312_bb1050","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: A major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/j.pharmthera.2022.108312_bb1055","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0304-3959(94)00268-J","article-title":"Morphine and morphine metabolite concentrations in cerebrospinal fluid and plasma in cancer pain patients after slow-release oral morphine administration","volume":"62","author":"Wolff","year":"1995","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2022.108312_bb1060","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0304-3959(96)03102-8","article-title":"Concentrations of morphine and morphine metabolites in CSF and plasma during continuous subcutaneous morphine administration in cancer pain patients","volume":"68","author":"Wolff","year":"1996","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2022.108312_bb1065","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1742-2094-10-23","article-title":"Toll-like receptor 4 mediates microglial activation and production of inflammatory mediators in neonatal rat brain following hypoxia: Role of TLR4 in hypoxic microglia","volume":"10","author":"Yao","year":"2013","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2022.108312_bb1070","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1081\/CLT-58950","article-title":"Key concepts in postmortem drug redistribution","volume":"43","author":"Yarema","year":"2005","journal-title":"Clinical Toxicology (Philadelphia, Pa.)"},{"key":"10.1016\/j.pharmthera.2022.108312_bb1075","first-page":"331","article-title":"The relevance of the OPRM1 118A>G genetic variant for opioid requirement in pain treatment: A meta-analysis","volume":"22","author":"Zhang","year":"2019","journal-title":"Pain Physician"},{"key":"10.1016\/j.pharmthera.2022.108312_bb1080","doi-asserted-by":"crossref","first-page":"32618","DOI":"10.1074\/jbc.M504942200","article-title":"Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G","volume":"280","author":"Zhang","year":"2005","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2022.108312_bb1085","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.forsciint.2017.07.006","article-title":"Postmortem blood sampling-comparison of drug concentrations at different sample sites","volume":"278","author":"Zilg","year":"2017","journal-title":"Forensic Science International"},{"key":"10.1016\/j.pharmthera.2022.108312_bb1090","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1126\/science.1078546","article-title":"COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor","volume":"299","author":"Zubieta","year":"2003","journal-title":"Science"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725822002066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725822002066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:05:43Z","timestamp":1777493143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725822002066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":218,"alternative-id":["S0163725822002066"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108312","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological data science perspective on fatal incidents of morphine treatment","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108312","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108312"}}